Why is Oxygenta Pharma falling/rising?

As of 25-Jun, Oxygenta Pharmaceutical Ltd is experiencing a price increase, currently at 124.00, reflecting a change of 2.0 or 1.64% upward. The stock has shown strong performance today, outperforming its sector by 0.59%, and reached an intraday high of Rs 127.81, which is a 4.76% increase. Over the past week, the stock has risen by 2.48%, and it has demonstrated impressive returns over longer periods, including a 250.68% increase over the past year. The company has reported positive results for the last five consecutive quarters, with net sales reaching their highest at Rs 49.47 crore. However, it is important to note that the company has a negative book value and a weak long-term fundamental strength, which may pose risks to its valuation despite the recent price increase.
In the broader market context, Oxygenta Pharma's short-term return of 2.48% over the past week surpasses the Sensex's return of 1.61% during the same period. This indicates that the stock is not only performing well on its own but is also gaining traction compared to the broader market. While the stock has shown remarkable growth over the past year and has outperformed the BSE 500 in various time frames, concerns remain regarding its high debt levels and negative EBITDA, which could impact investor sentiment moving forward.